Brazilian Patent for FGF2-STAB

Masaryk University and Enantis have been granted the Brazilian patent for FGF2-STAB—a genetically engineered fibroblast growth factor 2!

This thermostable molecule, created through protein engineering, provides a novel approach to growing FGF2-dependent cell cultures more efficiently, requiring fewer media changes.

FGF2-STAB is a game-changer because it helps maintain cells in the pluripotent state. This makes the cells invaluable for studying embryogenesis, accelerating drug discovery, and advancing cell-based therapies.